Approval · Notice of Compliance 17122 · 2015
MEMANTINE: Notice of Compliance 17122
Issued July 22, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17122
- Date
- July 22, 2015
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- N-methyl d-aspartate (nmda) receptor antagonist
- Canadian reference product
- EBIXA (Lundbeck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEMANTINE | 02443082 | Marketed |
Medicinal ingredients
- MEMANTINE HYDROCHLORIDE 10 MG per TAB